Clinician perspectives on communication and implementation challenges in precision oncology.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Personalized medicine Pub Date : 2021-09-01 Epub Date: 2021-10-22 DOI:10.2217/pme-2021-0048
Jada G Hamilton, Smita C Banerjee, Sigrid V Carlsson, Jacqueline Vera, Kathleen A Lynch, Lili Sar-Graycar, Chloé M Martin, Patricia A Parker, Jennifer L Hay
{"title":"Clinician perspectives on communication and implementation challenges in precision oncology.","authors":"Jada G Hamilton,&nbsp;Smita C Banerjee,&nbsp;Sigrid V Carlsson,&nbsp;Jacqueline Vera,&nbsp;Kathleen A Lynch,&nbsp;Lili Sar-Graycar,&nbsp;Chloé M Martin,&nbsp;Patricia A Parker,&nbsp;Jennifer L Hay","doi":"10.2217/pme-2021-0048","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> To describe patient communication challenges encountered by oncology clinicians, which represent a fundamental barrier to implementing precision oncology. <b>Materials & methods:</b> We conducted three focus groups including breast, melanoma and thoracic oncology clinicians regarding their precision oncology communication experiences. Transcripts were reviewed and coded using inductive thematic text analysis. <b>Results:</b> We identified four themes: varied definitions of precision oncology exist, clinicians and patients face unique challenges to precision oncology implementation, patient communication challenges engendered or heightened by precision oncology implementation and clinician communication solutions and training needs. <b>Conclusion:</b> This study elucidated clinicians' perspectives on implementing precision oncology and related communication challenges. Understanding these challenges and developing strategies to help clinicians navigate these discussions are critical for ensuring that patients reap the full benefits of precision oncology.</p>","PeriodicalId":19753,"journal":{"name":"Personalized medicine","volume":"18 6","pages":"559-572"},"PeriodicalIF":1.7000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607478/pdf/pme-18-559.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pme-2021-0048","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3

Abstract

Aim: To describe patient communication challenges encountered by oncology clinicians, which represent a fundamental barrier to implementing precision oncology. Materials & methods: We conducted three focus groups including breast, melanoma and thoracic oncology clinicians regarding their precision oncology communication experiences. Transcripts were reviewed and coded using inductive thematic text analysis. Results: We identified four themes: varied definitions of precision oncology exist, clinicians and patients face unique challenges to precision oncology implementation, patient communication challenges engendered or heightened by precision oncology implementation and clinician communication solutions and training needs. Conclusion: This study elucidated clinicians' perspectives on implementing precision oncology and related communication challenges. Understanding these challenges and developing strategies to help clinicians navigate these discussions are critical for ensuring that patients reap the full benefits of precision oncology.

临床医生对精准肿瘤学中沟通和实施挑战的看法。
目的:描述肿瘤临床医生遇到的患者沟通挑战,这是实施精确肿瘤学的根本障碍。材料与方法:我们对乳腺、黑色素瘤和胸部肿瘤临床医生进行了三个焦点小组,了解他们的精准肿瘤学交流经验。使用归纳主题文本分析对转录本进行审查和编码。结果:我们确定了四个主题:存在不同的精确肿瘤定义,临床医生和患者在实施精确肿瘤方面面临独特的挑战,患者沟通挑战产生或加剧了精确肿瘤的实施,临床医生沟通解决方案和培训需求。结论:本研究阐明了临床医生对实施精准肿瘤学和相关沟通挑战的看法。了解这些挑战并制定策略来帮助临床医生引导这些讨论,对于确保患者获得精确肿瘤学的全部益处至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Personalized medicine
Personalized medicine 医学-药学
CiteScore
3.30
自引率
4.30%
发文量
49
审稿时长
6-12 weeks
期刊介绍: Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信